Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
出版年份 2021 全文链接
标题
Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-01-14
DOI
10.3389/fphar.2020.600372
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chloroquine for the 2019 novel coronavirus SARS-CoV-2
- (2020) Philippe Colson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- The Science Underlying COVID-19: Implications for the Cardiovascular System
- (2020) Peter P. Liu et al. CIRCULATION
- Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors
- (2020) Zhenzhen Fan et al. EMBO Molecular Medicine
- The many faces of the anti-COVID immune response
- (2020) Santosha A. Vardhana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Rapid repurposing of drugs for COVID-19
- (2020) R. Kiplin Guy et al. SCIENCE
- Estimating the burden of SARS-CoV-2 in France
- (2020) Henrik Salje et al. SCIENCE
- Why COVID-19 Silent Hypoxemia Is Baffling to Physicians
- (2020) Martin J. Tobin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Structural Basis of the SARS-CoV-2/SARS-CoV Receptor Binding and Small-Molecule Blockers as Potential Therapeutics
- (2020) Hariharan Sivaraman et al. Annual Review of Pharmacology and Toxicology
- Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
- (2020) Clarisse Salgado-Benvindo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovering small-molecule therapeutics against SARS-CoV-2
- (2020) Vaibhav Tiwari et al. DRUG DISCOVERY TODAY
- Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
- (2020) Serena Di Cosimo et al. EUROPEAN JOURNAL OF CANCER
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
- (2020) Siyu Xiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Candidate drugs against SARS-CoV-2 and COVID-19
- (2020) Dwight L. McKee et al. PHARMACOLOGICAL RESEARCH
- How does SARS-CoV-2 cause COVID-19?
- (2020) Nicholas J. Matheson et al. SCIENCE
- A single unified model for fitting simple to complex receptor response data
- (2020) Peter Buchwald Scientific Reports
- Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial
- (2020) Daryoush Hamidi Alamdari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Methylene blue inhibits the replication of SARS-Cov-2 in vitro
- (2020) Mathieu Gendrot et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology
- (2019) Martin C. Michel et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
- (2018) Alassane Dicko et al. LANCET INFECTIOUS DISEASES
- Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40–CD154 Costimulatory Protein-Protein Interaction
- (2018) Damir Bojadzic et al. MOLECULES
- Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010
- (2017) Nicholas S. Downing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Small-Molecule Inhibitors of the CD40–CD40L Costimulatory Protein–Protein Interaction
- (2017) Jinshui Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction
- (2014) Yun Song et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modulators of Protein–Protein Interactions
- (2014) Lech-Gustav Milroy et al. CHEMICAL REVIEWS
- Plasma Treated with Methylene Blue and Light: Clinical Efficacy and Safety Profile
- (2013) Miguel Lozano et al. TRANSFUSION MEDICINE REVIEWS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- The food colorant erythrosine is a promiscuous protein–protein interaction inhibitor
- (2011) Lakshmi Ganesan et al. BIOCHEMICAL PHARMACOLOGY
- “Lest we forget you — methylene blue …”
- (2011) R. Heiner Schirmer et al. NEUROBIOLOGY OF AGING
- Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods
- (2010) Christelle Reynès et al. PLoS Computational Biology
- Suramin inhibits the CD40–CD154 costimulatory interaction: A possible mechanism for immunosuppressive effects
- (2009) Emilio Margolles-Clark et al. BIOCHEMICAL PHARMACOLOGY
- Rationalizing the chemical space of protein–protein interaction inhibitors
- (2009) Olivier Sperandio et al. DRUG DISCOVERY TODAY
- Small-molecule costimulatory blockade: organic dye inhibitors of the CD40–CD154 interaction
- (2009) Emilio Margolles-Clark et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- High absolute bioavailability of methylene blue given as an aqueous oral formulation
- (2008) Ingeborg Walter-Sack et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started